undefined undefined
NaN.000
NaN.00%
Net sales of $321.6 million with net income of $24.0 million and adjusted EBITDA(1) of $43.4 million Operating cash flow of $33.4 million with ending cash and cash equivalents of $278.1 mill...
05-10 04:10
Providing a diverse range of perspectives from bullish to bearish, 4 analysts h...
05-08 03:00
Ligand Pharmaceuticals (NASDAQ:LGND) and Agenus (AGEN) said they have entered into a royalty financing agreement to support AGEN's key development initiatives in the ongoing BOT/BAL clinical developme...
05-07 20:02
$1.06 PER SHARE NET INCOME $1.31 PER SHARE NON-GAAP OPERATING EARNINGS Reaffirms 2024 Non-GAAP Operating Earnings Guidance of $3.60 - $3.70 Per Share NEWARK, N.J., April 30, 2024 /PRNewswire...
04-30 19:30
Takeda Pharmaceutical (NYSE:TAK) has decided to part ways with the biotech industry's top lobbying group, the Biotechnology Innovation Organization (BIO), Stat News reported. With its departure taking...
04-26 03:35
Gainers Immutep (NASDAQ:IMMP) stock increased by 15.5% to $2.9 during Wednesda...
04-24 20:06
Remains hopeful that SilverBow's Board will reverse course and start engaging i...
04-11 19:30
Ovid Therapeutics (NASDAQ:OVID) traded higher on Friday after Wedbush launched its coverage with an Outperform recommendation citing the company’s therapeutic pipeline dominated by small molecules. Re...
04-06 01:53
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OV...
04-04 20:00
In the last three months, 5 analysts have published ratings on Moderna (NASDAQ:...
03-28 21:00